Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study

Safety and Effectiveness of Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Patients With Atrial Fibrillation and Anemia: A Retrospective Cohort Study

Background Major randomized trials assessing non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in atrial fibrillation generally excluded patients with hemoglobin <10 g/dL. This study evaluated the safety and effectiveness of NOACs in patients with atrial fibrillation and...

Full description

Bibliographic Details
Main Authors: Chun‐Li Wang, Victor Chien‐Chia Wu, Yu‐Tung Huang, Chang‐Fu Kuo, Pao‐Hsien Chu, Yu‐Ling Chen, Ming‐Shien Wen, Shang‐Hung Chang
Format: Article
Language:English
Published: Wiley 2019-05-01
Series:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:
anemia
anticoagulation
atrial fibrillation
bleeding
outcome
Online Access:https://www.ahajournals.org/doi/10.1161/JAHA.119.012029

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.119.012029

Similar Items